Clinical Trials: Evaluating Genetic Risk Factors for Childhood-onset Schizophrenia

Article

This study will evaluate familial risk factors for schizophrenia.

Study Type:

Observational

Age/Gender Requirements:

6 years+ (male/female)

Sponsor:

National Institute of Mental Health

Purpose:

Building on earlier research, the current study will evaluate familial risk factors for schizophrenia, including psychiatric diagnoses of family members, smooth pursuit eye movements, and neuropsychological test deficits.

Click here to access this third-party resource.

Recent Videos
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Why Are Adult ADHD Cases Climbing?
How to Adequately Screen for and Treat Cognitive Decline in Primary Care
Depression Screening: Challenges and Solutions at the Primary Care Level
James R. Kilgore, DMSc, PhD, PA-C: Cognitive Decline Diagnostics
HCPLive Five at APA 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.